BOSTON, MA, June 15, 2017 – The Boards of Trustees of Tekla Healthcare Investors (HQH), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW) are pleased to announce the results from the Funds’ joint annual shareholder meeting held today.
Shareholders re-elected Rakesh Jain and Lucinda Stebbins as Trustees of Tekla Healthcare Investors; Michael Bonney and Uwe Reinhardt as Trustees of Tekla Healthcare Opportunities Fund; and Rakesh Jain, Daniel Omstead and Lucinda Stebbins as Trustees of Tekla World Healthcare Fund.
The shareholders also ratified the selection of Deloitte & Touche LLP as the Independent Registered Public Accountants of each Fund for its fiscal year ending September 30, 2017.
Tekla Capital Management LLC is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of assets under management as of March 31, 2017. Tekla serves as investment adviser to four closed-end funds: Tekla Healthcare Investors (NYSE: HQH), Tekla Life Sciences Investors (NYSE: HQL), Tekla Healthcare Opportunities Fund (NYSE: THQ) and Tekla World Healthcare Fund (NYSE: THW) that invest in companies in the healthcare and life sciences industries. Information regarding each Fund and Tekla Capital Management LLC can be found at www.teklacap.com.
Destra Capital Investments is each Fund’s marketing and investor support services agent. Please contact Destra Capital Investments at (877)855-3434 if you have any questions.